From a press release on Senator Patrick Leahy's website:
One thing I don't like about the Leahy letter is the following statement; "...As a result, Myriad may continue to be the only company able to provide women with the genetic testing they need..." That "may" doesn't make clear that there are presently at least two cases pending challenging Myriad's genetic testing program. But these two labs being sued by Myriad are not the only ones offering the tests. According to one source:
" Emory Genetics Lab, GeneDx, Pathway Genomics, Ethigen, and the University of Washington announced they would offer BRCA testing after the Supreme Court's ruling in AMP v. Myriad."